Halozyme Therapeutics Inc (NAS:HALO)
$ 38.22 -0.55 (-1.42%) Market Cap: 4.86 Bil Enterprise Value: 6.08 Bil PE Ratio: 18.11 PB Ratio: 57.91 GF Score: 83/100

Halozyme Therapeutics Inc (HALO) Transcripts

  • 1